Clinical Trials
20
Active:0
Completed:14
Trial Phases
4 Phases
Phase 1:2
Phase 3:11
Phase 4:2
+1 more phases
Drug Approvals
76
PHILIPPINES:55
SFDA:21
Drug Approvals
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
Distribution across different clinical trial phases (19 trials with phase data)• Click on a phase to view related trials
Phase 3
11 (57.9%)Not Applicable
3 (15.8%)Phase 1
2 (10.5%)Phase 4
2 (10.5%)phase_1_2
1 (5.3%)Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2022-03-03
- Last Posted Date
- 2022-03-03
- Lead Sponsor
- Venus Remedies Limited
- Target Recruit Count
- 24
- Registration Number
- NCT05265676
- Locations
- 🇮🇳
Cliantha Research Limited, Ahmedabad, Gujarat, India
CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria
Phase 3
Completed
- Conditions
- Acute PyelonephritisUrinary Tract Infection Complicated
- Interventions
- First Posted Date
- 2018-03-26
- Last Posted Date
- 2019-08-29
- Lead Sponsor
- Venus Remedies Limited
- Target Recruit Count
- 230
- Registration Number
- NCT03477422
- Locations
- 🇮🇳
Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Srinagar, Jammu & Kashmir, India
🇮🇳Sapthagiri Institute of Medical Sciences and Research Center, Bangalore, Karnataka, India
🇮🇳KLES, Dr Prabhakar Kore Hospital and Medical Centre , , India, Belgaum, Karnataka, India
News
No news found